Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +4.00% | +52.94% | -22.10% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.10% | 2.64M | |
+9.22% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.47% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.95% | 16.96B | |
+7.58% | 14.16B | |
+40.03% | 12.63B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Transcript : Cyclacel Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 13, 2023